NEU 0.26% $15.57 neuren pharmaceuticals limited

ACADIA earnings, page-24

  1. 2,021 Posts.
    lightbulb Created with Sketch. 477
    My view hasn’t changed, other than that I think ACAD could now get away with a takeover offer considerably less than the A$4.44 I hypothesized in my post.

    Well, from an Acadia shareholder perspective, they won't want to see the company paying what appears to be multiples in an offer, so I'd say we'll get that rise into the low-mid $3 then the mid $4 offer will come. I expect the timing to be around July/August when NEU shareholders have to roll the dice on the P3 outcome. Wild card is the NASDAQ listing, which I tend to think is hot air.

    On the other hand, P2 results for 2591 (ASAP) are a real inflection point to the outcome of the determined value of the company. Get the bulk of the $24 million spent creating value, rather than handing it over in some deal I say!

    Little T - without Lang's position as a take-over barrier - do we have a 'cohesive-enough' register to fend off something aggressive from Acadia - in your view?

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.57
Change
-0.040(0.26%)
Mkt cap ! $1.990B
Open High Low Value Volume
$15.83 $15.87 $15.20 $8.124M 524.8K

Buyers (Bids)

No. Vol. Price($)
1 64 $15.49
 

Sellers (Offers)

Price($) Vol. No.
$15.58 597 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.